On 17 August 2017
ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 17 August 2017, to consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter /Three months ended June 30, 2017Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
